Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-25Clinical Trial Results: Nirogacestat in Ovarian Granulosa Cell Tumors [Phase 2]
Phase 2 clinical trial results for nirogacestat in ovarian granulosa cell tumors have been completed with posted results.
-
CLINICAL_TRIALS trial_result · 2026-08-24Clinical Trial Results: Efficacy of Plasmid Elenagen in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Cancer [Phase 2]
Phase 2 trial results for elenagen plasmid in combination with gemcitabine show efficacy in platinum-resistant ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2026-08-18Clinical Trial Results: Michigan Genetic Hereditary Testing (MiGHT) [NA]
Results from the MiGHT genetic hereditary testing trial conducted at University of Michigan Rogel Cancer Center in breast, colorectal, and o…
-
CLINICAL_TRIALS trial_result · 2026-08-13Clinical Trial Results: A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluating NC410 plus pembrolizumab in advanced/metastatic solid tumors with various MSI statuses; terminated with posted re…
-
CLINICAL_TRIALS trial_result · 2026-08-05Clinical Trial Results: Durvalumab and Tremelimumab in Treating Participants With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
Phase 2 clinical trial assessing durvalumab and tremelimumab in recurrent or refractory ovarian, primary peritoneal, or fallopian tube cance…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-08-05Clinical Trial Results: Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod [Phase 2]
Phase 2 trial evaluating dendritic cell/tumor fusions with GM-CSF and Imiquimod in ovarian cancer and related peritoneal cancers; study term…
-
CLINICAL_TRIALS trial_result · 2026-07-31Clinical Trial Results: ROCKIF Trial: Re-sensitization of Carboplatin-resistant Ovarian Cancer With Kinase Inhibition of FAK [Phase 1, Phase 2]
Phase 1/2 trial evaluating FAK kinase inhibitor to re-sensitize carboplatin-resistant ovarian cancer; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2026-07-13Clinical Trial Results: A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer [Phase 1, Phase 2]
Phase 1/2 trial results for TC-510 in advanced mesothelin-expressing cancers were terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2026-07-09Clinical Trial Results: A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study of pegylated IL-10 (pegilodecakin) in adults with advanced solid tumors; results from a first-in-human trial assessing safety …
-
CLINICAL_TRIALS trial_result · 2026-06-18Clinical Trial Results: A Study of CRLX101(NLG207) in Combination With Weekly Paclitaxel in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer [Phase 1, Phase 2]
Phase 1/2 study evaluating CRLX101 (NLG207) with weekly paclitaxel in recurrent/persistent epithelial ovarian, Fallopian tube, or primary pe…
-
CLINICAL_TRIALS trial_result · 2026-06-12Clinical Trial Results: Olvi-Vec Oncolytic Immunotherapy in Patients With Recurrent or Refractory Ovarian Cancer [Phase 1, Phase 2]
Phase 1/2 trial results for Olvi-Vec oncolytic immunotherapy in recurrent or refractory ovarian cancer show completed study with posted resu…
-
CLINICAL_TRIALS trial_result · 2026-06-09Clinical Trial Update: Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients [Phase 3]
Phase 3 clinical trial evaluating durvalumab with chemotherapy and bevacizumab followed by maintenance durvalumab, bevacizumab, and olaparib…
-
CLINICAL_TRIALS trial_result · 2026-06-04Clinical Trial Results: Alpelisib Plus Olaparib in Platinum-resistant/Refractory, High-grade Serous Ovarian Cancer, With no Germline BRCA Mutation Detected [Phase 3]
Phase 3 trial evaluating alpelisib plus olaparib in platinum-resistant/refractory high-grade serous ovarian cancer without germline BRCA mut…
-
CLINICAL_TRIALS trial_result · 2026-06-03Clinical Trial Results: Bevacizumab and/or Niraparib in Patients With Recurrent Endometrial and/or Ovarian Cancer With ARID1A Mutation [Phase 2]
Phase 2 trial evaluating bevacizumab and/or niraparib in patients with recurrent endometrial or ovarian cancer harboring ARID1A mutation; st…
-
CLINICAL_TRIALS trial_result · 2026-06-02Clinical Trial Update: Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer [Phase 3]
A Phase 3 trial evaluating mirvetuximab soravtansine with bevacizumab versus bevacizumab alone as maintenance therapy in platinum-sensitive …
-
CLINICAL_TRIALS trial_result · 2026-04-28Clinical Trial Results: A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer [Phase 2]
Phase 2 trial results of a precision medicine approach (SMMART-ACT) in patients with advanced sarcoma, breast, ovarian, pancreatic, or prost…
-
EMA approval · 2026-04-24EMA Authorised: Caelyx pegylated liposomal (doxorubicin hydrochloride) — Baxter Holding B.V.
EMA authorised Caelyx pegylated liposomal doxorubicin hydrochloride for Kaposi's sarcoma, multiple myeloma, ovarian cancer, and breast cance…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk
A completed clinical trial evaluating risk-reducing removal of the ovaries/fallopian tubes and CA-125 screening to lower ovarian cancer risk…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies
This clinical trial update describes tissue acquisition and genomics analysis of breast cancer and other gynecologic malignancies, with enro…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Prediction of Germline BRCA 1/2 Genes From Healthy Ovaries
A clinical trial is exploring predicting germline BRCA1/2 gene status from healthy ovarian tissue and is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Ovarian Tumor Organotypic Slices Cultures for functionAl Drug Testing and Therapy Response Prediction [NA]
This clinical trial update describes a study using ovarian tumor organotypic slice cultures to functionally test drugs and predict therapy r…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer [Phase 2]
Phase 2 clinical trial evaluating autologous T cells engineered to express T-cell receptors against neoantigens in metastatic cancer, curren…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Intervention of Ovarian Cancer With Antigen-specific Engineered Immune Effectors [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating antigen-specific engineered immune effectors for ovarian cancer is currently enrolling by invitation.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer [Phase 1]
Phase 1 trial evaluating adding abemaciclib to olaparib in women with recurrent ovarian cancer, including high-grade serous and platinum-res…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Tiaoshen Anti-cancer Protocol and CBT for Insomnia and Survival in Ovarian Cancer [Phase 2, Phase 3]
Clinical trial update describing a phase 2/3 study of the Tiaoshen anti-cancer protocol combined with cognitive behavioral therapy for insom…